Register Login

All Posts

More on AB Plasma to Correct Bleeding

Jose DeJesus‘ November 9 question about providing plasma to an AB patientbecame a dinner-table discussion at my house. You may think, “What a sad, dull existence–a two-MLS family,” however, we’ve turned up some interesting information by communicating with acquaintances at three institutions. First, if you can give incompatible platelet concentrate, why not incompatible plasma? There are […]
read more

New Results on Rivaroxaban

Research data presented Sunday, November 13, 2011 at the American Heart Association Scientific Sessions indicated that adding low doses of Johnson & Johnson and Bayer’s Xarelto (rivaroxaban) to standard antiplatelet therapy significantly prevented the occurrence of secondary cardiovascular events in patients with acute coronary syndrome (ACS), compared with standard therapy alone. The companies plan to seek US […]
read more